ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 154 filers reported holding ARRAY BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $5,556,000 | +100.0% | 119,925 | +5.2% | 0.00% | +50.0% |
| Q1 2019 | $2,778,000 | +116.7% | 113,943 | +26.6% | 0.00% | +100.0% |
| Q4 2018 | $1,282,000 | +11.6% | 89,972 | +19.0% | 0.00% | 0.0% |
| Q3 2018 | $1,149,000 | -10.4% | 75,632 | -1.0% | 0.00% | 0.0% |
| Q2 2018 | $1,282,000 | -2.7% | 76,399 | -5.3% | 0.00% | 0.0% |
| Q1 2018 | $1,317,000 | -1.1% | 80,685 | -22.3% | 0.00% | 0.0% |
| Q4 2017 | $1,331,000 | +32.8% | 103,783 | +27.2% | 0.00% | 0.0% |
| Q3 2017 | $1,002,000 | +77.0% | 81,578 | +20.6% | 0.00% | – |
| Q2 2017 | $566,000 | +13.2% | 67,656 | +20.6% | 0.00% | – |
| Q1 2017 | $500,000 | +39.7% | 56,110 | +37.3% | 0.00% | – |
| Q4 2016 | $358,000 | +145.2% | 40,854 | +76.0% | 0.00% | – |
| Q3 2016 | $146,000 | +78.0% | 23,211 | 0.0% | 0.00% | – |
| Q2 2016 | $82,000 | +17.1% | 23,211 | 0.0% | 0.00% | – |
| Q1 2016 | $70,000 | -34.0% | 23,211 | -9.5% | 0.00% | – |
| Q4 2015 | $106,000 | -11.7% | 25,657 | 0.0% | 0.00% | – |
| Q3 2015 | $120,000 | -35.1% | 25,657 | 0.0% | 0.00% | – |
| Q2 2015 | $185,000 | -3.6% | 25,657 | 0.0% | 0.00% | – |
| Q1 2015 | $192,000 | +56.1% | 25,657 | 0.0% | 0.00% | – |
| Q4 2014 | $123,000 | +28.1% | 25,657 | 0.0% | 0.00% | – |
| Q3 2014 | $96,000 | – | 25,657 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |